Declaration

In line with the recent GST change announced by the Government of India, Novartis India Limited and Novartis Healthcare Private Limited have revised the medicine prices with the lower GST rates. The revised prices have been implemented with effect from 22/9/25, reflecting our commitment to comply with government regulations and to making treatments more affordable for patients. Novartis has also conveyed the revised prices to its CFA’s and stockiest with a request to intimate the same to retailers so that the same can be implemented immediately and pass the benefit of reduced prices to the patients.